Navigation Links
Kosan Announces Data Presentations at Upcoming AACR Annual Meeting

HAYWARD, Calif., April 10, 2007 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated announced data will be presented on the Company's clinical and preclinical pipeline, including its Hsp90 inhibitor, epothilone and nuclear export inhibitor programs, at the 2007 Annual Meeting of the American Association for Cancer Research (AACR), being held in Los Angeles, April 14-18, 2007.

Poster presentations on Kosan's programs are as follows. The location for all poster presentations is the Los Angeles Convention Center Exhibit Hall.

    Date   Abstract #   Title             Session          Poster  Poster #



    1:00-  1544         Tanespimycin:     Experimental     32      4

    5:00                 No effects on     and Molecular

                         QTC interval      Therapeutics 13

                         using two



    1:00-  1568         Preclinical       Experimental     32      28

    5:00                 safety profile    and Molecular

                         of tanespimycin   Therapeutics 13

                         (KOS-5: 953) --

                         a heat shock

                         protein 90




    1:00-  1438         KOS-1803: A new,  Experimental     27      19

    5:00                 rationally        and Molecular

                         designed          Therapeutics 8


                         analog with an



                         profile and

                         efficacy in

                         xenograft mouse



    8:00-  5597         Anti-tumor        Experimental     29      2

    12:00                activity of       and Molecu

Page: 1 2 3

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
9. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
Post Your Comments:
(Date:1/15/2014)... 2014  Research and Markets ( ) ... Consumables Market - Global Industry Analysis, Size, Share, ... report to their offering. (Logo: ... consumables are products which are used on patients ... restoration and in treatment of associated gingival tissues. ...
(Date:1/15/2014)... 2014 AARP Foundation today announced it has ... adults suffering from the severe cold weather that has ... are committed to helping those in need; so to ... will match dollar-for-dollar contributions up to $250,000, which could ... will be administered through AARP Foundation. ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate ... stock in an at-the-market registered direct offering, led ... The Company entered into definitive purchase agreements with ... to sell an aggregate of 3,603,603 shares of ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... 16, 2010 Cylene Pharmaceuticals, Inc. will present advances ... at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and ... Berlin, Germany. CX-4945 is the first and only CK2 ... exciting new approach for the treatment for many different ...
... 2010 announces that a new market ... Global Antibiotics Industry ... This report analyzes the worldwide markets for Antibiotics ... Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibiotics ...
Cached Medicine Technology:Cylene to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 2Cylene to Present Advances with Industry's Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR 3Reportlinker Adds Global Antibiotics Industry 2Reportlinker Adds Global Antibiotics Industry 3Reportlinker Adds Global Antibiotics Industry 4Reportlinker Adds Global Antibiotics Industry 5Reportlinker Adds Global Antibiotics Industry 6Reportlinker Adds Global Antibiotics Industry 7Reportlinker Adds Global Antibiotics Industry 8Reportlinker Adds Global Antibiotics Industry 9Reportlinker Adds Global Antibiotics Industry 10Reportlinker Adds Global Antibiotics Industry 11Reportlinker Adds Global Antibiotics Industry 12Reportlinker Adds Global Antibiotics Industry 13Reportlinker Adds Global Antibiotics Industry 14Reportlinker Adds Global Antibiotics Industry 15Reportlinker Adds Global Antibiotics Industry 16Reportlinker Adds Global Antibiotics Industry 17Reportlinker Adds Global Antibiotics Industry 18Reportlinker Adds Global Antibiotics Industry 19
(Date:4/16/2014)... fertility treatments are the leading cause of increases ... elevated risk of premature birth, these results are ... Fertility and Sterility . The article identifies ... reduce the odds of multiple births and prematurity, ... (IVF) and improving doctor-patient communications about the risks ...
(Date:4/15/2014)... Handling frozen fish caused nearly half of all injuries ... injuries on freezer-longliner vessels operating off the coast of ... Many of those injuries and others aboard the two ... interventions, and the research methods used in the study ... other types of commercial fishing, said researcher Devin Lucas. ...
(Date:4/15/2014)... Group published in the European Journal of Cancer ... categorization of tumor response or various aspects of progression ... database. They found that modeling target lesion tumor ... above and beyond that of the other components of ... United States National Cancer Institute, and the National Cancer ...
(Date:4/14/2014)... chemotherapy over the past decade, but targeting drugs to ... a major challenge. , Nanotechnology has unlocked new ... nanocarriers, or capsules, that can transport cargoes of small-molecule ... catch? These carriers are tiny, and it matters just ... nanometers to 100 nanometers, and the drugs can end ...
(Date:4/14/2014)... at Henry Ford Hospital reached a medical milestone ... replacement using a novel way to access the ... in the United States performing the unique procedure ... by temporarily connecting major blood vessels. , Northern ... first transcaval procedure on July 3, 2013 when ...
Breaking Medicine News(10 mins):Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Changes in processing, handling could reduce commercial fishing injuries 2Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Nano shake-up 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2
... Van Andel Research Institute (VARI) investigators working ... two types of kidney tumors previously thought to be ... This finding will help doctors to more accurately diagnose ... using molecular data to diagnose cancer in general. , ...
... May 9 is National VA Research Week, themed ... of VA investigators and,collaborators, as well as the ... VA research studies. With state-of-the-art electronic,records and close ... to,conduct crucial research. Because most of its researchers ...
... adolescents can have a long-term positive impact on sexual ... a new RAND Corporation study. , Researchers found that ... drug abuse prevention program as adolescents were less likely ... years later, according to the findings published online by ...
... New Screening Test Will Focus on 4.3 Million Annual ... Group Inc. (OTC Bulletin Board: BMSN) and Entest BioMedical ... has been signed with Dr. Brian Koos, a professor ... of Medicine at UCLA for the development, ...
... conferenceEPHRATA, Pa., April 29 Did you know ... breast cancer in Pennsylvania who are uninsured or underinsured? ... not aware of the program or how it can benefit ... Coalition (PBCC), in partnership with Senator Vince Hughes, is publicizing ...
... Mass., April 29 Waters ... the United States Drug Enforcement Administration (U.S. DEA) purchased ... of training new forensic chemists at the Special Testing ... important resource in assisting local, state and federal law ...
Cached Medicine News:Health News:Finding will improve accuracy of cancer diagnosis 2Health News:MultiVu Video Feed: VA Research Week Offers Glimpse into Medicine's Future 2Health News:Teen drug education also helps curb risky sexual behavior, study finds 2Health News:Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test 2Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:Waters Corporation Announces U.S. Drug Enforcement Administration Acquires Waters ACQUITY UPLC System to Train Forensic Chemists in Drug Screening and Profiling 2
The UltraLite Post Op Brace provides a fixed or range of motion control. The UltraLite Post Op Brace indications include: , Post knee trauma , Peri-operative use , Conservative management of isolated...
... was designed to meet the constant demands ... kit provides all components necessary to fit ... 1002-A4 Aluminum pre-contoured adjustable knee joints , ... 2 Unique adjustable thigh bands , Ortho-wick™ ...
... This lightweight orthosis is designed ... basilar joint while allowing unobstructed motion ... a more custom fit the splint ... and formed using a heat gun. ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: